CDT Equity Partners With QIMA Life Sciences On Autoimmune Skin Research, Shares Fall In Pre-market
(RTTNews) - US biotech group CDT Equity Inc. (CDT), announced on Friday that it has entered into a partnership with French contract research organization QIMA Life Sciences to explore the potential of several CDT assets in autoimmune skin diseases.